Published in Postgrad Med J on March 01, 1973
Immunological mechanisms of vaccination. Nat Immunol (2011) 3.35
Serum and nasal wash antibodies associated with resistance to experimental challenge with influenza A wild-type virus. J Clin Microbiol (1986) 3.33
Relationship between haemagglutination-inhibiting antibody titres and clinical protection against influenza: development and application of a bayesian random-effects model. BMC Med Res Methodol (2010) 2.46
Systems vaccinology. Immunity (2010) 2.36
High-efficiency incorporation of functional influenza virus glycoproteins into recombinant vesicular stomatitis viruses. J Virol (1997) 2.07
Chikungunya virus and prospects for a vaccine. Expert Rev Vaccines (2012) 1.69
High doses of purified influenza A virus hemagglutinin significantly augment serum and nasal secretion antibody responses in healthy young adults. J Clin Microbiol (1994) 1.61
Contributions of humoral and cellular immunity to vaccine-induced protection in humans. Virology (2011) 1.53
Interpretation of responses and protective levels of antibody against attenuated influenza A viruses using single radial haemolysis. J Hyg (Lond) (1984) 1.49
Rapidly produced SAM(®) vaccine against H7N9 influenza is immunogenic in mice. Emerg Microbes Infect (2013) 1.04
Further studies of the neuraminidase content of inactivated influenza vaccines and the neuraminidase antibody responses after vaccination of immunologically primed and unprimed populations. Infect Immun (1980) 0.98
Comparison of one- and two-dose regimens of influenza vaccine for elderly men. CMAJ (1987) 0.88
Preparation and properties of a novel influenza subunit vaccine. Postgrad Med J (1976) 0.86
Hemagglutination inhibiting antibodies and protection against seasonal and pandemic influenza infection. J Infect (2014) 0.84
Immunity toward H1N1 influenza hemagglutinin of historical and contemporary strains suggests protection and vaccine failure. Sci Rep (2013) 0.82
Influenza-Specific Antibody-Dependent Phagocytosis. PLoS One (2016) 0.81
A new approach to estimate vaccine efficacy based on immunogenicity data applied to influenza vaccines administered by the intradermal or intramuscular routes. Hum Vaccin (2010) 0.81
A surface antigen influenza vaccine. 2. Pyrogenicity and antigenicity. J Hyg (Lond) (1976) 0.81
Immunobiology of influenza vaccines. Chest (2013) 0.78
Chikungunya vaccines in development. Hum Vaccin Immunother (2016) 0.76
Standardized viral hemagglutination and hemagglutination-inhibition tests. II. Description and statistical evaluation. Appl Microbiol (1969) 4.99
Protective effects of specific immunity to viral neuraminidase on influenza virus infection of mice. J Virol (1968) 4.62
A common surface antigen in influenza viruses from human and avian sources. J Gen Virol (1968) 3.20
Studies with inactivated influenza vaccines purified by zonal centrifugation. 1. Adverse reactions and serological responses. Bull World Health Organ (1969) 2.28
The diagnosis of Asian influenza virus infection after recent immunization. U S Armed Forces Med J (1959) 2.03
Studies with avian influenza A viruses: cross protection experiments in chickens. J Gen Virol (1971) 1.66
Studies with inactivated influenza vaccines purified by zonal centrifugation. 2. Efficacy. Bull World Health Organ (1969) 1.55
A comparison of subcutaneous, nasal, and combined influenza vaccination. II. Protection against natural challenge. Am J Epidemiol (1971) 1.54
Legionnaires' disease: isolation of a bacterium and demonstration of its role in other respiratory disease. N Engl J Med (1977) 25.00
Influenzavirus neuraminidase and neuraminidase-inhibition test procedures. Bull World Health Organ (1973) 10.70
The epidemiology of AIDS: current status and future prospects. Science (1985) 8.73
The Hong Kong-68 influenza A2 variant. Lancet (1968) 5.25
Association of antigenic type of Herpesvirus hominis with site of viral recovery. J Immunol (1967) 5.07
A serologic study of herpesvirus hominis strains by microneutralization tests. J Immunol (1967) 4.39
Infections of cerebrospinal fluid shunts: epidemiology, clinical manifestations, and therapy. J Infect Dis (1975) 4.02
A 2020 vision for American health care. Arch Intern Med (2000) 4.01
Antigenic and biologic differences in herpesvirus hominis. Prog Med Virol (1968) 3.31
Prevalence of antibody to current influenza viruses and effect of vaccination on antibody response. Br Med J (1972) 3.10
The epidemiology of AIDS. Public Health Rep (1983) 3.00
Influenza--a preventable disease not being prevented. Am Rev Respir Dis (1986) 2.96
The swine-influenza decision. N Engl J Med (1976) 2.91
Swine influenza viruses isolated in 1976 from man and pig contain two coexisting subpopulations with antigenically distinguishable hemagglutinins. Virology (1977) 2.90
Antigenic similarity of influenza A (H1N1) viruses from epidemics in 1977--1978 to "Scandinavian" strains isolated in epidemics of 1950--1951. Virology (1978) 2.61
Optimal methods for guideline implementation: conclusions from Leeds Castle meeting. Med Care (2001) 2.41
Genital infection with type 2 Herpes virus hominis. A commonly occurring venereal disease. Br J Vener Dis (1969) 2.40
Relation of pock size on chorioallantoic membrane to antigenic type of herpesvirus hominis. Proc Soc Exp Biol Med (1968) 2.34
The risk of endothelial infection in adults with salmonella bacteremia. Ann Intern Med (1978) 2.29
Studies with inactivated influenza vaccines purified by zonal centrifugation. 1. Adverse reactions and serological responses. Bull World Health Organ (1969) 2.28
Adult pneumonia in a general hospital. Etiology and host risk factors. Arch Intern Med (1972) 2.24
The relation of endometriosis to menstrual characteristics, smoking, and exercise. JAMA (1986) 2.22
Tubal infertility and the intrauterine device. N Engl J Med (1985) 2.22
Association of maternal hematocrit with premature labor. Am J Obstet Gynecol (1988) 2.18
Isolation of swine influenza virus from autopsy lung tissue of man. N Engl J Med (1976) 2.09
Influenza vaccine--unacceptable or unaccepted. Am J Public Health (1979) 2.02
No association between coffee consumption and adverse outcomes of pregnancy. N Engl J Med (1982) 2.01
Stopping poliovirus vaccination after eradication: issues and challenges. Bull World Health Organ (2000) 2.00
Risk factors accounting for racial differences in the rate of premature birth. N Engl J Med (1987) 1.91
Identification and preliminary antigenic analysis of swine influenza-like viruses isolated during an influenza outbreak at Fort Dix, New Jersey. J Infect Dis (1977) 1.88
Natural history of influenza type A in the United States, 1957-1972. Prog Med Virol (1974) 1.79
Benefit-cost analysis of rubella vaccination policy. N Engl J Med (1976) 1.79
Sunlight and cholera. Lancet (1992) 1.78
Pertussis vaccine--an analysis of benefits, risks and costs. N Engl J Med (1979) 1.75
Airways function during mild viral respiratory illnesses. The effect of rhinovirus infection in cigarette smokers. Ann Intern Med (1974) 1.72
Antigenic variation in current influenza A viruses: evidence for a high frequency of antigenic 'drift' for the Hong Kong virus. Bull World Health Organ (1974) 1.68
Protein composition of coronavirus OC 43. Virology (1972) 1.66
Studies on inactivated influenza vaccines. II. Effect of increasing dosage on antibody response and adverse reactions in man. Am J Epidemiol (1970) 1.60
WHO collaborative study on the sero-epidemiology of rubella in Caribbean and Middle and South American populations in 1968. Bull World Health Organ (1970) 1.58
Age-related heterologous antibody responses to influenza virus vaccination. J Infect Dis (1977) 1.57
When is the quality of care good enough? Am J Public Health (1990) 1.55
Coronaviridae. Intervirology (1975) 1.55
Studies with inactivated influenza vaccines purified by zonal centrifugation. 2. Efficacy. Bull World Health Organ (1969) 1.55
Relationship of anatomic disease to appropriateness ratings of coronary angiography. Arch Intern Med (1995) 1.52
Swine influenza virus infections in humans. J Infect Dis (1977) 1.50
Seroepidemiologic survey of coronavirus (strain OC 43) related infections in a children's population. Am J Epidemiol (1971) 1.44
Risk factors for infection at the operative site after abdominal or vaginal hysterectomy. N Engl J Med (1982) 1.44
Clinical practice guidelines at an HMO: development and implementation in a quality improvement model. QRB Qual Rev Bull (1990) 1.42
Properties of the Hong Kong influenza virus. Antigenic relationship of the Hong Kong virus haemagglutinin to that of other human influenza A viruses. Bull World Health Organ (1969) 1.41
Epidemiology of influenza in the elderly: evidence of virus recycling. Am J Epidemiol (1976) 1.40
Neuraminidase content of influenza vaccines and neuraminidase antibody responses after vaccination of immunologically primed and unprimed populations. J Infect Dis (1977) 1.39
Genital infection with Herpesvirus hominis types 1 and 2 in children. Pediatrics (1968) 1.38
Genital herpes simplex infection in the female. Am J Obstet Gynecol (1966) 1.38
Ectopic pregnancy and prior induced abortion. Am J Public Health (1982) 1.37
Laboratory-based surveillance of influenza virus in the United States during the winter of 1977--1978. II. Isolation of a mixture of A/Victoria- and A/USSR-like viruses from a single person during an epidemic in Wyoming, USA, January 1978. Am J Epidemiol (1979) 1.37
Bacteremic infection in hemodialysis. Arch Intern Med (1979) 1.34
A theoretical look at the gender balance of power in the American couple. J Fam Issues (1989) 1.33
Antigenic variants of influenza B virus. Br Med J (1973) 1.31
Cigarettes, coffee, and preterm premature rupture of the membranes. Am J Epidemiol (1992) 1.31
Pilot application of a teaching technique in social medicine. J Med Educ (1969) 1.28
A simple double immunodiffusion test for typing influenza viruses. Bull World Health Organ (1974) 1.26
Influenza A neuraminidase antibody assay with sensitized erythrocytes. Appl Microbiol (1973) 1.26
Improving influenza vaccination performance in an HMO setting: the use of computer-generated reminders and peer comparison feedback. Am J Public Health (1990) 1.25
Reference equine antisera to 33 human adenovirus types: homologous and heterologous titers. J Clin Microbiol (1975) 1.25
Economic impact of influenza. The individual's perspective. Am J Med (1987) 1.23
Immunoglobulin class of influenza antibodies investigated by radioimmunoassay (RIA). J Immunol (1972) 1.21
A novel mechanism of resistance to penicillin-gentamicin synergism in Streptococcus faecalis. J Infect Dis (1980) 1.21
Inhibition of virus release by antibodies to surface antigens of influenza viruses. J Virol (1974) 1.21
Swine-like influenza virus infection in a Wisconsin farm family. J Infect Dis (1977) 1.20
Properties of the Hong Kong influenza virus. I. General characteristics of the Hong Kong virus. Bull World Health Organ (1969) 1.19
Immunological basis of the adenovirus 8-9 cross-reaction. J Virol (1970) 1.19
Antibodies to Herpesvirus hominis types 1 and 2 in the rabbit. J Immunol (1969) 1.18
Work and pregnancy. J Occup Med (1984) 1.17